This association between the CYP11A1-RORα/γ pathway and tumor progression suggests that activation of the alternative vitamin D metabolism pathway could be a novel preventive, as well as therapeutic, strategy for cancer. The gene discussed is CYP11A1; the disease is neoplasm.